Crystal structure of dot1l in complex with adenosine and inhibitor cpd1 [n6-(2,6-dichlorophenyl)-n6-(pent-2-yn-1-yl)quinoline-4,6-diamine] Deposition Author(s): Be, C. , Gaul, C. , Koch, E. , Moebitz, H. , Scheufler, C. , Stauffer, F.
Date: 2017-01-17 Method: X-RAY DIFFRACTION Resolution: 2.18 Å Organism(s): Homo Sapiens Sequences Data: 5MVS_A , 5MVS_B
Crystal structure of dot1l in complex with inhibitor cpd1 [n6-(2,6-dichlorophenyl)-n6-(pent-2-yn-1-yl)quinoline-4,6-diamine] and inhibitor cpd2 [(r)-1-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-amine] Deposition Author(s): Be, C. , Gaul, C. , Koch, E. , Moebitz, H. , Scheufler, C. , Stauffer, F.
Date: 2017-01-18 Method: X-RAY DIFFRACTION Resolution: 2.09 Å Organism(s): Homo Sapiens Sequences Data: 5MW3_A , 5MW3_B
Crystal structure of dot1l in complex with inhibitor cpd7 [n-(3-(((r)-1-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-yl)(methyl)amino)propyl)-2-(3-(2-chloro-3-(2-methylpyridin-3-yl)benzo[b]thiophen-5-yl)ureido)acetamide] Deposition Author(s): Be, C. , Gaul, C. , Koch, E. , Moebitz, H. , Scheufler, C. , Stauffer, F.
Date: 2017-01-18 Method: X-RAY DIFFRACTION Resolution: 2.19 Å Organism(s): Homo Sapiens Sequences Data: 5MW4_A , 5MW4_B
Crystal structure of dot1l in complex with an inhibitor (compound 3). Deposition Author(s): Be, C. , Moebitz, H. , Scheufler, C. , Stauffer, F.
Date: 2019-11-11 Method: X-RAY DIFFRACTION Resolution: 1.98 Å Organism(s): Homo Sapiens Sequences Data: 6TE6_A , 6TE6_B
Crystal structure of dot1l in complex with an inhibitor (compound 10). Deposition Author(s): Be, C. , Moebitz, H. , Scheufler, C. , Stauffer, F.
Date: 2019-11-12 Method: X-RAY DIFFRACTION Resolution: 2.19 Å Organism(s): Homo Sapiens Sequences Data: 6TEL_A , 6TEL_B
Crystal structure of dot1l in complex with an inhibitor (compound 11). Deposition Author(s): Be, C. , Moebitz, H. , Scheufler, C. , Stauffer, F.
Date: 2019-11-12 Method: X-RAY DIFFRACTION Resolution: 2.21 Å Organism(s): Homo Sapiens Sequences Data: 6TEN_A , 6TEN_B